Twist Bioscience (FRA:0ME) Additional Paid-In Capital : €1,547.9 Mil(As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Twist Bioscience Additional Paid-In Capital?

Twist Bioscience's quarterly additional paid-in capital declined from Sep. 2023 (€1,552.8 Mil) to Dec. 2023 (€1,528.5 Mil) but then increased from Dec. 2023 (€1,528.5 Mil) to Mar. 2024 (€1,547.9 Mil).

Twist Bioscience's annual additional paid-in capital increased from Sep. 2021 (€1,012.2 Mil) to Sep. 2022 (€1,635.8 Mil) but then declined from Sep. 2022 (€1,635.8 Mil) to Sep. 2023 (€1,552.8 Mil).

Twist Bioscience Additional Paid-In Capital Historical Data

The historical data trend for Twist Bioscience's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Twist Bioscience Additional Paid-In Capital Chart

Twist Bioscience Annual Data

Trend

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Additional Paid-In Capital

Get a 7-Day Free Trial

427.15

674.64

1,012.20

1,635.84

1,552.82

Twist Bioscience Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															1,525.43	1,518.31	1,552.82	1,528.45	1,547.88

Twist Bioscience Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Twist Bioscience Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Twist Bioscience's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Twist Bioscience (FRA:0ME) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Twist Bioscience Corp (FRA:0ME) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

TWST:USA 0ME:Germany

Address

681 Gateway Boulevard, South San Francisco, CA, USA, 94080

Website

https://www.twistbioscience.com

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of its revenue from the United States.

Twist Bioscience (FRA:0ME) Headlines

No Headlines